These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 11042653)
1. Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer. Reece DE; Foon KA; Bhattacharya-Chatterjee M; Hale GA; Howard DS; Munn RK; Nath R; Plummer BA; Teitelbaum A; Phillips GL Bone Marrow Transplant; 2000 Oct; 26(7):729-35. PubMed ID: 11042653 [TBL] [Abstract][Full Text] [Related]
2. Interim analysis of the use of the anti-idiotype breast cancer vaccine 11D10 (TriAb) in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer. Reece DE; Foon KA; Battacharya-Chatterjee M; Adkins D; Broun ER; Connaghan DG; Dipersio JF; Holland HK; Howard DS; Hale GA; Klingemann HG; Munn RK; Raptis A; Phillips GL Clin Breast Cancer; 2001 Apr; 2(1):52-8. PubMed ID: 11899383 [TBL] [Abstract][Full Text] [Related]
3. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. Porrata LF; Ingle JN; Litzow MR; Geyer S; Markovic SN Bone Marrow Transplant; 2001 Nov; 28(9):865-71. PubMed ID: 11781647 [TBL] [Abstract][Full Text] [Related]
4. Establishing a platform for immunotherapy: clinical outcome and study of immune reconstitution after high-dose chemotherapy with progenitor cell support in breast cancer patients. Sportès C; McCarthy NJ; Hakim F; Steinberg SM; Liewehr DJ; Weng D; Kummar S; Gea-Banacloche J; Chow CK; Dean RM; Castro KM; Marchigiani D; Bishop MR; Fowler DH; Gress RE Biol Blood Marrow Transplant; 2005 Jun; 11(6):472-83. PubMed ID: 15931636 [TBL] [Abstract][Full Text] [Related]
5. Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit. Kurian S; Qazilbash M; Fay J; Wolff S; Herzig R; Hobbs G; Bunner P; Weisenborn R; Aya-Ay M; Lynch J; Ericson S Breast J; 2006; 12(6):531-5. PubMed ID: 17238982 [TBL] [Abstract][Full Text] [Related]
6. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation. Demirer T; Uysal VA; Ayli M; Genc Y; Ilhan O; Koc H; Dagli M; Arat M; Gunel N; Fen T; Dincer S; Ustael N; Yildiz M; Ustun T; Seyrek E; Ozet G; Muftuoglu O; Akan H Bone Marrow Transplant; 2003 May; 31(9):755-61. PubMed ID: 12732881 [TBL] [Abstract][Full Text] [Related]
7. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16. Crump M; Gluck S; Tu D; Stewart D; Levine M; Kirkbride P; Dancey J; O'Reilly S; Shore T; Couban S; Girouard C; Marlin S; Shepherd L; Pritchard KI J Clin Oncol; 2008 Jan; 26(1):37-43. PubMed ID: 18025439 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of the effectiveness of chemotherapy and autologous hematopoietic stem cell transplantation as postremission treatment for adult acute lymphoblastic leukemia patients]. Jin FY; Zou DH; Wang GR; Xu Y; Feng SZ; Zhao YZ; Han MZ; Yan WW; Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):645-8. PubMed ID: 16620547 [TBL] [Abstract][Full Text] [Related]
9. A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903. Posner MC; Niedzwiecki D; Venook AP; Hollis DR; Kindler HL; Martin EW; Schilsky RL; Goldberg RM; Mayer RJ Ann Surg Oncol; 2008 Jan; 15(1):158-64. PubMed ID: 18008108 [TBL] [Abstract][Full Text] [Related]
10. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen. Foon KA; John WJ; Chakraborty M; Sherratt A; Garrison J; Flett M; Bhattacharya-Chatterjee M Clin Cancer Res; 1997 Aug; 3(8):1267-76. PubMed ID: 9815809 [TBL] [Abstract][Full Text] [Related]
11. Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study. Stemmler HJ; Salat C; Lindhofer H; Menzel H; Untch M; Kahlert S; Konecny G; Sauer H; Ledderose G; Heinemann V; Kolb HJ Anticancer Res; 2005; 25(4):3047-54. PubMed ID: 16080564 [TBL] [Abstract][Full Text] [Related]
12. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival. Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144 [TBL] [Abstract][Full Text] [Related]
13. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma. Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951 [TBL] [Abstract][Full Text] [Related]
14. Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2. Foon KA; Sen G; Hutchins L; Kashala OL; Baral R; Banerjee M; Chakraborty M; Garrison J; Reisfeld RA; Bhattacharya-Chatterjee M Clin Cancer Res; 1998 May; 4(5):1117-24. PubMed ID: 9607568 [TBL] [Abstract][Full Text] [Related]
15. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation. Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH; Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634 [TBL] [Abstract][Full Text] [Related]
16. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience. Rodríguez J; Conde E; Gutiérrez A; Arranz R; Gandarillas M; Leon A; Ojanguren J; Sureda A; Carrera D; Bendandi M; Moraleda J; Ribera JM; Albo C; Morales A; García JC; Fernández P; Cañigral G; Bergua J; Caballero MD; Eur J Haematol; 2007 Apr; 78(4):290-6. PubMed ID: 17378891 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation. Vij R; DiPersio J; Brown R; Trinkaus K; Abboud C; Meehan KR; Frenette G; Freytes C; Goodnough LT; Khoury H; Ponnuri J; Adkins D Bone Marrow Transplant; 2000 Nov; 26(9):947-53. PubMed ID: 11100273 [TBL] [Abstract][Full Text] [Related]
18. Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer. Schneeweiss A; Hensel M; Goerner R; Khbeis T; Hohaus S; Egerer G; Solomayer E; Haas R; Grischke EM; Bastert G; Ho AD Stem Cells; 2001; 19(2):151-60. PubMed ID: 11239170 [TBL] [Abstract][Full Text] [Related]
19. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study]. Shi Y; Pan F; Han X Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500 [TBL] [Abstract][Full Text] [Related]
20. Use of the anti-idiotype breast cancer vaccine 11D10 in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer. Reece DE; Foon KA; Bhattarcharya-Chatterjee M; Adkins D; Broun ER; Connaghan DG; Dipersio JF; Holland HK; Howard DA; Hale GA; Klingemann HG; Munn RK; Raptis A; Phillips GL Clin Breast Cancer; 2003 Feb; 3 Suppl 4():S152-7. PubMed ID: 12620153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]